Alchemab Therapeutics Ltd
Pioneering Patient-led Antibody Therapeutics
71 employees · est. 2019 · London, United Kingdom
Complix N.V.
Complix is a biopharmaceutical company leading the way in the use of biologics for challenging disease targets.
8 employees · est. 2008 · Diepenbeek, Belgium
Complix N.V. is the older company (2019 vs 2008); Alchemab Therapeutics Ltd is the larger of the two.
Side-by-Side Comparison
| Metric | Alchemab Therapeutics Ltd | Complix N.V. |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2008 older |
| Headquarters | ||
| Headquarters | London, United Kingdom | Diepenbeek, Belgium |
| Employees | ||
| Employees | 71 larger | 8 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series A | Grant |
| Total Funding | ||
| Total Funding | $145.82M | $21.90M |
| Funding Rounds | ||
| Funding Rounds | 8 | 5 |
| Services | ||
| Services | Development of antibody therapeutics, Conducting clinical trials, Biopharmaceutical partnerships, Deep learning in drug development | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare providers, Pharmaceutical companies, Cancer research organizations, Biotech investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Antibody Therapeutics, Patient-led Drug Discovery, Natural Protective Antibodies, Immunology, Hard-to-treat Diseases, Oncology Biotech, Neurodegenerative Diseases, Infectious Diseases, Biobank Collaboration, Function-first Approach, Innovative Drug Development, Biopharmaceutical Research, Collaborative Research, Biotech Disease Prevention | Biopharmaceutical Company, Biologics, Protein Therapeutics, Alphabody Technology, Cell Penetrating Technology, Intracellular Disease, Drug Discovery, Protein Scaffolds, Non-injectable Routes, Disease Targets, Therapeutic Proteins, Biotech, Pharmaceutical Research, Innovation, Technology Platforms |
| Website | ||
| Website | alchemab.com | complix.com |
About Alchemab Therapeutics Ltd
Alchemab Therapeutics Ltd, founded in 2019 and headquartered in the United Kingdom, is at the forefront of harnessing the natural power of patient antibodies to tackle hard-to-treat diseases. Their slogan, "Pioneering Patient-led Antibody Therapeutics," encapsulates their innovative approach in the...
About Complix N.V.
Complix N.V. is a biopharmaceutical company based in Belgium that is pioneering the use of biologics for challenging disease targets. The company was founded in 2008 and is dedicated to the discovery and development of protein therapeutics using its proprietary alphabody™ technology. Alphabodies, wh...
We will tell you when either one moves
BounceWatch watches Alchemab Therapeutics Ltd and Complix N.V. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Alchemab Therapeutics... and Complix N.V. — by email.
Frequently Asked Questions
Compare Alchemab Therapeutics Ltd with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Alchemab Therapeutics Ltd on 15 Jun 2026, and Complix N.V. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.